| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.296 | 2.973 | 4.341 | 3.988 | 4.899 | 1.800 | 2.244 | 2.109 | 0 | 0 |
| Total Income - EUR | 3.296 | 2.973 | 4.341 | 3.988 | 4.899 | 1.803 | 2.244 | 2.109 | 0 | 0 |
| Total Expenses - EUR | 3.665 | 3.774 | 3.860 | 2.716 | 1.774 | 1.960 | 1.241 | 2.055 | 0 | 1.106 |
| Gross Profit/Loss - EUR | -369 | -801 | 481 | 1.273 | 3.126 | -157 | 1.003 | 54 | 0 | -1.106 |
| Net Profit/Loss - EUR | -468 | -890 | 351 | 1.153 | 2.978 | -211 | 937 | -9 | 0 | -1.106 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cabinet Opticlar Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 36 | 62 | 101 | 301 | 1.936 | 1.677 | 2.567 | 78 | 71 | 71 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3 | 0 | 0 | 0 | 0 | 372 | 0 | 0 | 0 | 0 |
| Cash | 34 | 62 | 101 | 301 | 1.936 | 1.305 | 2.567 | 78 | 71 | 71 |
| Shareholders Funds | -1.816 | -2.688 | -2.291 | -1.096 | 1.904 | 1.656 | 2.556 | 71 | 71 | -1.035 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 1.852 | 2.750 | 2.393 | 1.397 | 32 | 21 | 11 | 7 | 0 | 1.106 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Opticlar Med S.r.l.